Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

NCT07047014 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

596

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Ischemic
Medium Vessel Occlusions

Interventions

DRUG: Tenecteplase (0.25mg/kg)
DRUG: Standard medical treatment

Sponsor

Beijing Tiantan Hospital

Collaborators

First Affiliated Hospital of Zhejiang University
Chinese Stroke Association